| 1 |
Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction
Li ZN, Shu Y, Chen CG, Li XQ, Li MY, Zhao XH, Wang S, Li J
Biochemical and Biophysical Research Communications, 528(3), 554, 2020 |
| 2 |
Functional Analysis of Ribonucleotide Reductase from Cordyceps militaris Expressed in Escherichia coli
Kato T, Ahmad S, Park EY
Applied Biochemistry and Biotechnology, 182(4), 1307, 2017 |
| 3 |
p53R2 regulates thioredoxin reductase activity through interaction with TrxR2
Park SJ, Kim HB, Piao C, Kang MY, Park SG, Kim SW, Lee JH
Biochemical and Biophysical Research Communications, 482(4), 706, 2017 |
| 4 |
The forkhead-like transcription factor (Fhl1p) maintains yeast replicative lifespan by regulating ribonucleotide reductase 1 (RNR1) gene transcription
Tai A, Kamei Y, Mukai Y
Biochemical and Biophysical Research Communications, 488(1), 218, 2017 |
| 5 |
E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2
Fang ZJ, Gong CJ, Liu H, Zhang XM, Mei LM, Song MT, Qiu LL, Luo SC, Zhu ZH, Zhang RH, Gu HQ, Chen X
Biochemical and Biophysical Research Communications, 464(2), 407, 2015 |
| 6 |
Simultaneous determination of deoxycytidine diphosphate and deoxycytidine triphosphate by capillary electrophoresis with transient isotachophoretic stacking: A sensitive monitoring method for ribonucleotide reductase activity
Huang SW, Tzeng HF
Electrophoresis, 33(3), 536, 2012 |
| 7 |
Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)
Avval FZ, Berndt C, Pramanik A, Holmgren A
Biochemical and Biophysical Research Communications, 379(3), 775, 2009 |
| 8 |
Protein splicing of the three Pyrococcus abyssi ribonucleotide reductase inteins
Kerrigan AM, Powers TL, Dorval DM, Reitter JN, Mills KV
Biochemical and Biophysical Research Communications, 387(1), 153, 2009 |
| 9 |
Essential role of Chk1 in S phase progression through regulation of RNR2 expression
Naruyama H, Shimada M, Niida H, Zineldeen DH, Hashimoto Y, Kohri K, Nakanishi M
Biochemical and Biophysical Research Communications, 374(1), 79, 2008 |
| 10 |
Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles
Bartlett DW, Davis ME
Biotechnology and Bioengineering, 99(4), 975, 2008 |
